ALN-3133 sodium is a siRNA targeting VEGF and is one of the siRNAs in ALN-VSP. ALN-VSP is a lipid nanoparticle formulation containing two siRNAs against kinesin spindle protein (KSP) and VEGF, offering potential antitumor activity.
Target:
VEGFR
* VAT and and shipping costs not included. Errors and price changes excepted
